Utama › Leukemia Mieloid Akut › Illinois › Cicero
Kajian klinikal Leukemia Mieloid Akut di Cicero, IL
11 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Cicero (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Mengambil pesertaFasa 2
- Edward Hines Jr VA Hospital, Hines · 4 mi jauh
- Loyola University Medical Center, Maywood · 5 mi jauh
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
- dan 2 lagi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi jauh
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Loyola University Medical Center, Maywood · 5 mi jauh
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Edward Hines Jr VA Hospital, Hines · 4 mi jauh
- Loyola University Medical Center, Maywood · 5 mi jauh
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Loyola University Medical Center, Maywood · 5 mi jauh
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Edward Hines Jr VA Hospital, Hines · 4 mi jauh
- Loyola University Medical Center, Maywood · 5 mi jauh
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Mengambil pesertaFasa 3
- Loyola University Medical Center, Maywood · 5 mi jauh
- Advocate Children's Hospital-Oak Lawn, Oak Lawn · 9 mi jauh
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Mengambil pesertaFasa 1/2
- Loyola University Medical Center, Maywood · 5 mi jauh
- Advocate Children's Hospital-Oak Lawn, Oak Lawn · 9 mi jauh
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Loyola University Medical Center, Maywood · 5 mi jauh
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- Loyola University Medical Center, Maywood · 5 mi jauh
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Mengambil pesertaFasa 1
- Loyola University Medical Center, Maywood · 5 mi jauh
Kajian Leukemia Mieloid Akut di bandar lain
- Houston, TX85 kajian
- New York City, NY51 kajian
- Boston, MA44 kajian
- Seattle, WA41 kajian
- Baldwin Park, CA40 kajian
- Columbus, OH35 kajian
- Philadelphia, PA34 kajian
- Durham, NC33 kajian
- Atlanta, GA31 kajian
- Tampa, FL29 kajian
- Chicago, IL26 kajian
- Portland, OR25 kajian
Kajian lain di Cicero
- Kanser Paru-paru Bukan Sel Kecil24 kajian
- Kanser Paru-paru17 kajian
- Kanser Prostat14 kajian
- Kanser (semua jenis)13 kajian
- Kanser Payudara11 kajian
- Kanser Kolorektal10 kajian
- Kanser Pundi Kencing8 kajian
- Melanoma7 kajian
- Penyakit Kardiovaskular7 kajian
- Kanser Metastatik7 kajian
- Mieloma Pelbagai6 kajian
- Limfoma Burkitt6 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.